Neumora was established with the aim of enhancing the quality of life for individuals affected by brain disorders. One of the main obstacles encountered is the limited availability of specific and efficient medications. Neumora is unwavering in its dedication to uncovering, formulating, and bringing to the market targeted treatments for individuals coping with brain disorders. We are convinced that an evidence-based precision medicine approach to pharmaceutical development will enhance the likelihood of creating efficient medications.